US Patent Issued to Abbott Diabetes Care on June 9 for "NAD(P) depot for NAD(P)-dependent enzyme-based sensors" (California, Nevada Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,944, issued on June 9, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"NAD(P) depot for NAD(P)-dependent enzyme-based sensors" was invented by Tianmei Ouyang (Saratoga, Calif.), Cade Fox (Alameda, Calif.), Zenghe Liu (Alameda, Calif.), Stephen Oja (Reno, Nev.) and Benjamin J. Feldman (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides analyte sensors including one or more NAD(P)-dependent enzymes and an internal supply of NAD(P) for the detection of an analyte. The present disclosure further provides methods of using such analyte sensors for detecting one or more analytes present in a biologi...